Does Bone Morphogenetic Protein Change the Operative Nonunion Rates in Spine Fusions?

被引:26
作者
Guppy, Kern H. [1 ,2 ]
Paxton, Elizabeth W. [3 ]
Harris, Jessica [3 ]
Alvarez, Julie [3 ]
Bernbeck, Johannes [4 ]
机构
[1] Kaiser Permanente Med Grp, Dept Neurosurg, Sacramento, CA 95825 USA
[2] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA
[3] Kaiser Permanente, Surg Outcomes & Anal Unit Clin Anal, San Diego, CA USA
[4] Kaiser Permanente So Calif, Dept Orthopaed, Baldwin Pk, CA USA
关键词
bone morphogenetic protein; operative nonunion; pseudarthrosis; spinal fusions; BMP; ANTERIOR CERVICAL DISKECTOMY; LUMBAR INTERBODY FUSION; PROTEIN-2/COMPRESSION RESISTANT MATRIX; ILIAC-CREST AUTOGRAFT; DEGENERATIVE DISEASE; POLYETHERETHERKETONE SPACER; RADIOGRAPHIC OUTCOMES; CLINICAL-OUTCOMES; HOSPITAL CHARGES; RHBMP-2;
D O I
10.1097/BRS.0000000000000534
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Study Design. A retrospective cohort study with medical record review. Objective. To determine if there is difference in the operative nonunion rates with and without the use of bone morphogenetic protein (BMP) after spinal fusions by analyzing data from an integrated health care system's spine registry. Summary of Background Data. BMP was first approved in 2002 for use in single-level anterior lumbar fusions. Follow-up studies have advocated its use in reducing the need for reoperations for nonunions. Recent studies, however, have questioned these conclusions and the usefulness of BMP in spinal fusions has been highly debated. Methods. We identified 9425 spinal fusion cases between 2009 and 2011 from a spine registry in a large integrated health care organization. Patient characteristics, diagnosis, operative times, length of stay, and reoperations were extracted from the registry. Reoperations for nonunions were adjudicated via medical record review. Cox regression models were used to evaluate the risk of reoperation while adjusting for confounders. Results. In our cohort, there were 5456 BMP cases and 3969 non-BMP cases. The mean age was 60.4 years (standard deviation: 12.9 yr), with the majority being females (53%). The median follow-up time was 1.2 years (interquartile range: 0.6-2.0 yr). Reoperation rates for BMP versus non-BMP nonunions for all fusion cases with follow-up of 1 year or more (1.9% vs. 2.2%) and follow-up of 2 years or more (2.3% vs. 2.6%) were not statistically significantly different. Operative nonunion rates did not reach statistical significance for different spine regions and for different fused columns (anterior only, posterior only, or combined). After controlling for differences in patient characteristics, operative times, levels fused, and spinal regions, the risk of reoperation in the BMP versus non-BMP groups was 0.67 (95% CI: 0.42-1.06). Conclusion. In this large cohort of spinal fusions at all spine regions involving all fused columns with and without BMP, we found no statistically significant difference in operative nonunion rates.
引用
收藏
页码:1831 / 1839
页数:9
相关论文
共 53 条
[1]
Economic evaluation of bone morphogenetic protein Versus autogenous iliac crest bone graft in single-level anterior lumbar fusion -: An evidence-based modeling approach [J].
Ackerman, SJ ;
Mafilios, MS ;
Polly, DW .
SPINE, 2002, 27 (16) :S94-S99
[2]
Effectiveness and Safety of Recombinant Human Bone Morphogenetic Protein-2 Versus Local Bone Graft in Primary Lumbar Interbody Fusions [J].
Adams, Cameron Louis ;
Ogden, Kathryn ;
Robertson, Iain Kilpatrick ;
Broadhurst, Stephen ;
Edis, David .
SPINE, 2014, 39 (02) :164-171
[3]
A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR™ allograft ring and the ATLANTIS™ anterior cervical plate [J].
Baskin, DS ;
Ryan, P ;
Sonntag, V ;
Westmark, R ;
Widmayer, MA .
SPINE, 2003, 28 (12) :1219-1224
[4]
Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein [J].
Boakye, M ;
Mummaneni, PV ;
Garrett, M ;
Rodts, G ;
Haid, R .
JOURNAL OF NEUROSURGERY-SPINE, 2005, 2 (05) :521-525
[5]
The use of rhBMP-2 in interbody fusion cages - Definitive evidence of osteoinduction in humans: A preliminary report [J].
Boden, SD ;
Zdeblick, TA ;
Sandhu, HS ;
Heim, SE .
SPINE, 2000, 25 (03) :376-381
[6]
Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans - A prospective, randomized clinical pilot trial - 2002 Volvo Award in clinical studies [J].
Boden, SD ;
Kang, J ;
Sandhu, H ;
Heller, JG .
SPINE, 2002, 27 (23) :2662-2673
[7]
Use of rhBMP-2 in combination with structural cortical allografts: Clinical and radiographic outcomes in anterior lumbar spinal surgery [J].
Burkus, JK ;
Sandhu, HS ;
Gornet, MF ;
Longley, MC .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2005, 87A (06) :1205-1212
[8]
Is INFUSE bone graft superior to autograft bone? An integrated analysis of clinical trials using the LT-CAGE lumbar tapered fusion device [J].
Burkus, JK ;
Heim, TE ;
Gornet, MF ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2003, 16 (02) :113-122
[9]
Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages [J].
Burkus, JK ;
Gornet, MF ;
Dickman, CA ;
Zdeblick, TA .
JOURNAL OF SPINAL DISORDERS & TECHNIQUES, 2002, 15 (05) :337-349
[10]
Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2 [J].
Burkus, JK ;
Transfeldt, EE ;
Kitchel, SH ;
Watkins, RG ;
Balderston, RA .
SPINE, 2002, 27 (21) :2396-2408